Choi, Jin-Ho http://orcid.org/0000-0003-4839-913X
Chun, Byeong Jo
Yeom, Seok Ran
Chung, Sung Phil
Lee, Young Hwan
Kim, Yun-Hee
Lee, Ji Sung
Lee, Jin Hwan
Lee, Hwan Goo
Jin, Jing Yu
An, Chun San
Gwag, Byoung Joo
Funding for this research was provided by:
Ministry of Health and Welfare of the Republic of Korea (HI20C0410)
GNTPharma
Article History
Received: 7 April 2022
Accepted: 8 June 2022
First Online: 23 July 2022
Declarations
:
: This trial will be conducted in accordance with the Declaration of Helsinki and international standards of Good Clinical Practice (GCP). The trial protocol has been approved by the Ministry of Food and Drug Safety of Korea on December 20, 2017 (# 11771), and was approved by the Institutional Review Board of Samsung Medical Center and each participating institute.
: The model consent forms given to the participants and authorized surrogates are written in the Korean language and available on reasonable request.
: J.L., G.L., J.J., C.A., and B.G. are employees of GNT Pharma. All the other authors declare that they have no competing interests.